Good practice guide for cervical ultrasound scan and echo-guided techniques in treating differentiated thyroid cancer of vesicular origin

Annales d'Endocrinologie

Volumn 72, Issue 3, 2011, Pages 173-197

  Leenhardt, L ^a   Borson Chazot, F ^b   Calzada, M ^c   Carnaille, B ^d   Charrie A ^b   Cochand Priollet, B ^e   Cao, C D ^d   Leboulleux, S ^f   Le Clech, G ^g   Mansour, G ^a   Menegaux, F ^a   Monpeyssen, H ^a   Orgiazzi, J ^b   Rouxel, A ^a   Sadoul, J L ^h   Schlumberger, M ^a   Tramalloni, J ⁱ   Tranquart, F ^a   Wemeau, J L ^f  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g RENNES UNIVERSITY HOSPITAL   (France)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁱ Bracco Suisse SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CANCER RECURRENCE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTRAST ENHANCEMENT; CYTOLOGY; DIAGNOSTIC IMAGING; DIFFERENTIATED THYROID CANCER; ECHOGRAPHY; ELASTOGRAPHY; HUMAN; LOBECTOMY; LYMPH NODE METASTASIS; PATIENT IDENTIFICATION; PATIENT MONITORING; PATIENT SELECTION; PRACTICE GUIDELINE; PROGNOSIS; RECURRENCE RISK; RISK ASSESSMENT; THYROIDECTOMY; ULTRASOUND THERAPY;

ADENOMA; CARCINOMA; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; THYROID NEOPLASMS; THYROIDECTOMY; ULTRASONOGRAPHY;

EID: 79959354676     PISSN: 00034266     EISSN: 00034266     Source Type: Journal    
DOI: 10.1016/j.ando.2011.04.001     Document Type: Article

References (109)

1. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Sherman S.I., Tuttle R.M. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006, 16:109-142.
2. Pacini F., Schlumberger M., Dralle H., Elisei R., Smit J.W., Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006, 154:787-803.
3. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Pacini F., Schlumberger M., Sherman S.I., Steward D.L., Tuttle R.M. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19:1167-1214.
4. Borson-Chasot F., Bardet S., Bournaud C., Conte-Devolx B., Corone C., D'Herbomez M., Henry J.F., Leenhardt L., Peix J.L., Schlumberger M., Wemeau J.L., Baudin E., Berger N., Bernard M.H., Calzada-Nocaudie M., Caron P., Catargi B., Chabrier G., Charrie A., Franc B., Hartl D., Helal B., Kerlan V., Kraimps J.L., Leboulleux S., Le Clech G., Menegaux F., Orgiazzi J., Perie S., Raingeard I., Rodien P., Rohmer V., Sadoul J.L., Schwartz C., Tenenbaum F., Toubert M.E., Tramalloni J., Travagli J.P., Vaudrey C. Guidelines for the management of differentiated thyroid carcinomas of vesicular origin. Ann Endocrinol (Paris) 2008, 69:472-486.
5. Leboulleux S., Girard E., Rose M., Travagli J.P., Sabbah N., Caillou B., Hartl D.M., Lassau N., Baudin E., Schlumberger M. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007, 92:3590-3594.
6. Frasoldati A., Pesenti M., Gallo M., Caroggio A., Salvo D., Valcavi R Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 2003, 97:90-96.
7. Frazell E.L., Foote F.W. Papillary thyroid carcinoma: pathological findings in cases with and without clinical evidence of cervical node involvement. Cancer 1955, 8:1164-1166.
8. Cady B., Sedgwick C.E., Meissner W.A., Bookwalter J.R., Romagosa V., Werber J. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976, 184:541-553.
9. McConahey W.M., Hay I.D., Woolner L.B., van Heerden J.A., Taylor W.F. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986, 61:978-996.
10. Zaydfudim V., Feurer I.D., Griffin M.R., Phay J.E. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 2008, 144:1070-1077. [discussion 1077-1078].
11. Leboulleux S., Rubino C., Baudin E., Caillou B., Hartl D.M., Bidart J.M., Travagli J.P., Schlumberger M. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005, 90:5723-5729.
12. Shimamoto K., Satake H., Sawaki A., Ishigaki T., Funahashi H., Imai T. Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 1998, 29:4-10.
13. Roh J.L., Park J.Y., Kim J.M., Song C.J. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol 2009, 99:28-31.
14. Bonnet S., Hartl D., Leboulleux S., Baudin E., Lumbroso J.D., Al Ghuzlan A., Chami L., Schlumberger M., Travagli J.P. Prophylactic lymph node dissection for papillary thyroid cancer less than 2cm: Implications for radioiodine treatment. J Clin Endocrinol Metab 2009, 94:1162-1167.
15. Hay I.D. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990, 19:545-576.
16. Rouxel A., Hejblum G., Bernier M.O., Boelle P.Y., Menegaux F., Mansour G., Hoang C., Aurengo A., Leenhardt L. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2004, 89:5362-5368.
17. Kitamura Y., Shimizu K., Nagahama M., Sugino K., Ozaki O., Mimura T., Ito K., Ito K., Tanaka S. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999, 84:4043-4049.
18. Torlontano M., Crocetti U., Augello G., D'Aloiso L., Bonfitto N., Varraso A., Dicembrino F., Modoni S., Frusciante V., Di Giorgio A., Bruno R., Filetti S., Trischitta V. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 2006, 91:60-63.
19. Pelttari H., Laitinen K., Schalin-Jantti C., Valimaki M.J. Long-term outcome of 495 TNM stage I or II patients with differentiated thyroid carcinoma followed up with neck ultrasonography and thyroglobulin measurements on T4 treatment. Clin Endocrinol (Oxf) 2008, 69:323-331.
20. DeGroot L.J., Kaplan E.L., McCormick M., Straus F.H. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990, 71:414-424.
21. Mazzaferri E.L., Kloos R.T. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001, 86:1447-1463.
22. Noguchi M., Yagi H., Earashi M., Kinoshita K., Miyazaki I., Mizukami Y. Recurrence and mortality in patients with differentiated thyroid carcinoma. Int Surg 1995, 80:162-166.
23. Ortiz S., Rodriguez J.M., Parrilla P., Perez D., Moreno-Gallego A., Rios A., Soria T. Recurrent papillary thyroid cancer: analysis of prognostic factors including the histological variant. Eur J Surg 2001, 167:406-412.
24. Schlumberger M. Papillary and follicular thyroid carcinoma. N Engl J Med 1998, 338:297-306.
25. Sugino K., Kure Y., Iwasaki H., Ozaki O., Mimura T., Matsumoto A., Ito K. Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma. Surg Today 1995, 25:324-328.
26. Mazzaferri E.L., Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994, 97:418-428.
27. Kloos R.T. Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer. J Clin Endocrinol Metab 2008, 93:1519-1525.
28. Mazzaferri E.L. Changing paradigms in the follow-up of patients with differentiated thyroid cancer: an alternative to [18F]fluorodeoxyglucose positron emission tomographic scanning. Endocr Pract 2003, 9:324-326.
29. Schlumberger M., Pacini F., Wiersinga W.M., Toft A., Smit J.W., Sanchez Franco F., Lind P., Limbert E., Jarzab B., Jamar F., Duntas L., Cohen O., Berg G. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 2004, 151:539-548.
30. Schlumberger M., Hitzel A., Toubert M.E., Corone C., Troalen F., Schlageter M.H., Claustrat F., Koscielny S., Taieb D., Toubeau M., Bonichon F., Borson-Chazot F., Leenhardt L., Schvartz C., Dejax C., Brenot-Rossi I., Torlontano M., Tenenbaum F., Bardet S., Bussiere F., Girard J.J., Morel O., Schneegans O., Schlienger J.L., Prost A., So D., Archambeaud F., Ricard M., Benhamou E. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007, 92:2487-2495.
31. Pacini F., Capezzone M., Elisei R., Ceccarelli C., Taddei D., Pinchera A. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 2002, 87:1499-1501.
32. Pacini F., Molinaro E., Castagna M.G., Agate L., Elisei R., Ceccarelli C., Lippi F., Taddei D., Grasso L., Pinchera A. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003, 88:3668-3673.
33. Tubiana M., Schlumberger M., Rougier P., Laplanche A., Benhamou E., Gardet P., Caillou B., Travagli J.P., Parmentier C. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985, 55:794-804.
34. Torlontano M., Attard M., Crocetti U., Tumino S., Bruno R., Costante G., D'Azzo G., Meringolo D., Ferretti E., Sacco R., Arturi F., Filetti S. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 2004, 89:3402-3407.
35. Torlontano M., Crocetti U., D'Aloiso L., Bonfitto N., Di Giorgio A., Modoni S., Valle G., Frusciante V., Bisceglia M., Filetti S., Schlumberger M., Trischitta V. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer. Eur J Endocrinol 2003, 148:19-24.
36. Pacini F. Follow-up of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2002, 29(Suppl. 2):S492-496.
37. Kim E., Park J.S., Son K.R., Kim J.H., Jeon S.J., Na D.G. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography. Thyroid 2008, 18:411-418.
38. Sigstad E., Heilo A., Paus E., Holgersen K., Groholt K.K., Jorgensen L.H., Bogsrud T.V., Berner A., Bjoro T. The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay. Diagn Cytopathol 2007, 35:761-767.
39. Uruno T., Miyauchi A., Shimizu K., Tomoda C., Takamura Y., Ito Y., Miya A., Kobayashi K., Matsuzuka F., Amino N., Kuma K. Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 2005, 29:483-485.
40. Borel A.L., Boizel R., Faure P., Barbe G., Boutonnat J., Sturm N., Seigneurin D., Bricault I., Caravel J.P., Chaffanjon P., Chabre O. Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer. Eur J Endocrinol 2008, 158:691-698.
41. Cunha N., Rodrigues F., Curado F., Ilheu O., Cruz C., Naidenov P., Rascao M.J., Ganho J., Gomes I., Pereira H., Real O., Figueiredo P., Campos B., Valido F. Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer. Eur J Endocrinol 2007, 157:101-107.
42. Pacini F., Fugazzola L., Lippi F., Ceccarelli C., Centoni R., Miccoli P., Elisei R., Pinchera A. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. J Clin Endocrinol Metab 1992, 74:1401-1404.
43. Snozek C.L., Chambers E.P., Reading C.C., Sebo T.J., Sistrunk J.W., Singh R.J., Grebe S.K. Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases. J Clin Endocrinol Metab 2007, 92:4278-4281.
44. Lee M.J., Ross D.S., Mueller P.R., Daniels G.H., Dawson S.L., Simeone J.F. Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis. Radiology 1993, 187:851-854.
45. Boi F., Baghino G., Atzeni F., Lai M.L., Faa G., Mariotti S. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. J Clin Endocrinol Metab 2006, 91:1364-1369.
46. Robbins K.T. Classification of neck dissection: current concepts and future considerations. Otolaryngol Clin North Am 1998, 31:639-655.
47. Carty S.E., Cooper D.S., Doherty G.M., Duh Q.Y., Kloos R.T., Mandel S.J., Randolph G.W., Stack B.C., Steward D.L., Terris D.J., Thompson G.B., Tufano R.P., Tuttle R.M., Udelsman R. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009, 19:1153-1158.
48. Tramalloni J., Monpeyssen H. Échographie de la thyroïde 2003, Elsevier SAS, Paris.
49. Shin J.H., Han B.K., Ko E.Y., Kang S.S. Sonographic findings in the surgical bed after thyroidectomy: comparison of recurrent tumors and nonrecurrent lesions. J Ultrasound Med 2007, 26:1359-1366.
50. Ying M., Ahuja A. Sonography of neck lymph nodes. Part I: normal lymph nodes. Clin Radiol 2003, 58:351-358.
51. Ahuja A.T., Ying M. Sonographic evaluation of cervical lymph nodes. AJR Am J Roentgenol 2005, 184:1691-1699.
52. Bruneton J.N., Balu-Maestro C., Marcy P.Y., Melia P., Mourou M.Y. Very high frequency (13MHz) ultrasonographic examination of the normal neck: detection of normal lymph nodes and thyroid nodules. J Ultrasound Med 1994, 13:87-90.
53. Solbiati L., Osti V., Cova L., Tonolini M. Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol 2001, 11:2411-2424.
54. Ying M., Ahuja A., Brook F., Brown B., Metreweli C. Sonographic appearance and distribution of normal cervical lymph nodes in a Chinese population. J Ultrasound Med 1996, 15:431-436.
55. Ying M., Ahuja A., Brook F. Sonographic appearances of cervical lymph nodes: variations by age and sex. J Clin Ultrasound 2002, 30:1-11.
56. Ying M., Ahuja A., Brook F. Repeatability of power Doppler sonography of cervical lymph nodes. Ultrasound Med Biol 2002, 28:737-744.
57. Wada N., Duh Q.Y., Sugino K., Iwasaki H., Kameyama K., Mimura T., Ito K., Takami H., Takanashi Y. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 2003, 237:399-407.
58. Roh J.L., Park J.Y., Rha K.S., Park C.I. Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma?. Head Neck 2007, 29:901-906.
59. Roh J.L., Kim J.M., Park C.I. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection. Ann Surg Oncol 2008, 15:1177-1182.
60. Roh J.L., Kim J.M., Park C.I. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 2008, 15:2482-2486.
61. Sivanandan R., Soo K.C. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg 2001, 88:1241-1244.
62. Kupferman M.E., Patterson M., Mandel S.J., LiVolsi V., Weber R.S. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130:857-860.
63. Machens A., Holzhausen H.J., Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg 2004, 139:43-45.
64. Ahuja A., Ying M. Sonographic evaluation of cervical lymphadenopathy: is power Doppler sonography routinely indicated?. Ultrasound Med Biol 2003, 29:353-359.
65. Frasoldati A., Valcavi R. Challenges in neck ultrasonography: lymphadenopathy and parathyroid glands. Endocr Pract 2004, 10:261-268.
66. Vassallo P., Wernecke K., Roos N., Peters P.E. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 1992, 183:215-220.
67. Ahuja A., Ying M. Sonography of neck lymph nodes. Part II: abnormal lymph nodes. Clin Radiol 2003, 58:359-366.
68. van den Brekel M.W., Castelijns J.A., Snow G.B. The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it?. AJNR Am J Neuroradiol 1998, 19:695-700.
69. Kuna S.K., Bracic I., Tesic V., Kuna K., Herceg G.H., Dodig D. Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 2006, 25:1531-1537. [quiz 1538-1540].
70. Steinkamp H.J., Cornehl M., Hosten N., Pegios W., Vogl T., Felix R. Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy. Br J Radiol 1995, 68:266-270.
71. Ahuja A.T., King W., Metreweli C. Role of ultrasonography in thyroid metastases. Clin Radiol 1994, 49:627-629.
72. Ahuja A.T., Ying M., Yuen H.Y., Metreweli C. Power Doppler sonography of metastatic nodes from papillary carcinoma of the thyroid. Clin Radiol 2001, 56:284-288.
73. Ahuja A., Ying M., King A., Yuen H.Y. Lymph node hilus: gray scale and power Doppler sonography of cervical nodes. J Ultrasound Med 2001, 20:987-992. [quiz 994].
74. Wunderbaldinger P., Harisinghani M.G., Hahn P.F., Daniels G.H., Turetschek K., Simeone J., O'Neill M.J., Mueller P.R. Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol 2002, 178:693-697.
75. Kessler A., Rappaport Y., Blank A., Marmor S., Weiss J., Graif M. Cystic appearance of cervical lymph nodes is characteristic of metastatic papillary thyroid carcinoma. J Clin Ultrasound 2003, 31:21-25.
76. Ahuja A.T., Chow L., Chick W., King W., Metreweli C. Metastatic cervical nodes in papillary carcinoma of the thyroid: ultrasound and histological correlation. Clin Radiol 1995, 50:229-231.
77. Ying M., Ahuja A., Brook F., Metreweli C. Power Doppler sonography of normal cervical lymph nodes. J Ultrasound Med 2000, 19:511-517.
78. Faquin W.C. The thyroid gland: recurring problems in histologic and cytologic evaluation. Arch Pathol Lab Med 2008, 132:622-632.
79. Scopa C.D., Melachrinou M., Saradopoulou C., Merino M.J. The significance of the grooved nucleus in thyroid lesions. Mod Pathol 1993, 6:691-694.
80. Bernier M.O., Moisan C., Mansour G., Aurengo A., Menegaux F., Leenhardt L. Usefulness of fine needle aspiration cytology in the diagnosis of loco-regional recurrence of differentiated thyroid carcinoma. Eur J Surg Oncol 2005, 31:288-293.
81. Kim M.J., Kim E.K., Kim B.M., Kwak J.Y., Lee E.J., Park C.S., Cheong W.Y., Nam K.H. Thyroglobulin measurement in fine-needle aspirate washouts: The criteria for neck node dissection for patients with thyroid cancer. Clin Endocrinol (Oxf) 2009, 70:145-151.
82. Filie A.C., Asa S.L., Geisinger K.R., Logani S., Merino M., Nikiforov Y.E., Clark D.P. Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008, 36:438-441.
83. Arturi F., Russo D., Giuffrida D., Ippolito A., Perrotti N., Vigneri R., Filetti S. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997, 82:1638-1641.
84. Baskin H.J. Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes. Thyroid 2004, 14:959-963.
85. Baloch Z.W., Barroeta J.E., Walsh J., Gupta P.K., Livolsi V.A., Langer J.E., Mandel S.J. Utility of thyroglobulin measurement in fine-needle aspiration biopsy specimens of lymph nodes in the diagnosis of recurrent thyroid carcinoma. Cytojournal 2008, 5:1.
86. Frasoldati A., Toschi E., Zini M., Flora M., Caroggio A., Dotti C., Valcavi R. Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer. Thyroid 1999, 9:105-111.
87. Cignarelli M., Ambrosi A., Marino A., Lamacchia O., Campo M., Picca G., Giorgino F. Diagnostic utility of thyroglobulin detection in fine-needle aspiration of cervical cystic metastatic lymph nodes from papillary thyroid cancer with negative cytology. Thyroid 2003, 13:1163-1167.
88. Stulak J.M., Grant C.S., Farley D.R., Thompson G.B., van Heerden J.A., Hay I.D., Reading C.C., Charboneau J.W. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg 141:489-494; discussion 2006, 141:489-494. [discussion 494-486].
89. Cailleux A.F., Baudin E., Travagli J.P., Ricard M., Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?. J Clin Endocrinol Metab 2000, 85:175-178.
90. Schlumberger M., Berg G., Cohen O., Duntas L., Jamar F., Jarzab B., Limbert E., Lind P., Pacini F., Reiners C., Sanchez Franco F., Toft A., Wiersinga W.M. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 2004, 150:105-112.
91. Baudin E., Do Cao C., Cailleux A.F., Leboulleux S., Travagli J.P., Schlumberger M. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 2003, 88:1107-1111.
92. Toubeau M., Touzery C., Arveux P., Chaplain G., Vaillant G., Berriolo A., Riedinger J.M., Boichot C., Cochet A., Brunotte F. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 2004, 45:988-994.
93. do Rosario P.W., Borges M.A., Alves M.F., Purisch S., Padrao E.L., Rezende L.L., Barroso A.L. Follow-up of high-risk patients with differentiated thyroid cancer without persistent disease after initial therapy. Arq Bras Endocrinol Metabol 2006, 50:909-913.
94. Kloos R.T., Mazzaferri E.L. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 2005, 90:5047-5057.
95. Tranquart F., Correas J., Bouakaz A. Échographie de contraste 2007, Springer Ed., Paris.
96. Appetecchia M., Bacaro D., Brigida R., Milardi D., Bianchi A., Solivetti F. Second generation ultrasonographic contrast agents in the diagnosis of neoplastic thyroid nodules. J Exp Clin Cancer Res 2006, 25:325-330.
97. Bartolotta T.V., Midiri M., Galia M., Runza G., Attard M., Savoia G., Lagalla R., Cardinale A.E. Qualitative and quantitative evaluation of solitary thyroid nodules with contrast-enhanced ultrasound: initial results. Eur Radiol 2006, 16:2234-2241.
98. Asteria C., Giovanardi A., Pizzocaro A., Cozzaglio L., Morabito A., Somalvico F., Zoppo A. US-elastography in the differential diagnosis of benign and malignant thyroid nodules. Thyroid 2008, 18:523-531.
99. Bae U., Dighe M., Dubinsky T., Minoshima S., Shamdasani V., Kim Y. Ultrasound thyroid elastography using carotid artery pulsation: preliminary study. J Ultrasound Med 2007, 26:797-805.
100. Tranquart F., Bleuzen A., Pierre-Renoult P., Chabrolle C., Sam Giao M., Lecomte P. Elastosonography of thyroid lesions. J Radiol 2008, 89:35-39.
101. Rago T., Santini F., Scutari M., Pinchera A., Vitti P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 2007, 92:2917-2922.
102. Lyshchik A., Higashi T., Asato R., Tanaka S., Ito J., Mai J.J., Pellot-Barakat C., Insana M.F., Brill A.B., Saga T., Hiraoka M., Togashi K. Thyroid gland tumor diagnosis at US elastography. Radiology 2005, 237:202-211.
103. Rubaltelli L., Corradin S., Dorigo A., Stabilito M., Tregnaghi A., Borsato S., Stramare R. Differential diagnosis of benign and malignant thyroid nodules at elastosonography. Ultraschall Med 2008.
104. Esnault O., Franc B., Monteil J.P., Chapelon J.Y. High-intensity focused ultrasound for localized thyroid-tissue ablation: preliminary experimental animal study. Thyroid 2004, 14:1072-1076.
105. Esnault O., Leenhardt L. High intensity focused ultrasound (HIFU) ablation therapy for thyroid nodules 2008, Elsevier SAS.
106. Esnault O., Franc B., Chapelon J.Y. Localized ablation of thyroid tissue by high-intensity focused ultrasound: improvement of noninvasive tissue necrosis methods. Thyroid 2009, 19:1085-1091.
107. Esnault O, Rouxel A, Le Nestour E, Gheron G, Leenhardt L. 2010 Minimally invasive ablation of a toxic thyroid nodule by high-intensity focused ultrasound. AJNR Am J Neuroradiol 2010;31:1967-68.
108. Sohn Y.M., Hong S.W., Kim E.K., Kim M.J., Moon H.J., Kim S.J., Son E.J., Kwak J.Y. Complete eradication of metastatic lymph node after percutaneous ethanol injection therapy: pathologic correlation. Thyroid 2009, 19:317-319.
109. Rotondi M., Amabile G., Leporati P., Di Filippo B., Chiovato L. Repeated laser thermal ablation of a large functioning thyroid nodule restores euthyroidism and ameliorates constrictive symptoms. J Clin Endocrinol Metab 2009, 94:382-383.